Goldman Sachs Group »

Madrigal Pharmaceuticals shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Madrigal Pharmaceuticals (MDGL) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Madrigal Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Madrigal Pharmaceuticals held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Madrigal Pharmaceuticals by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $57M 202k 280.16
2024-03-31 $27M 101k 267.04
2023-12-31 $22M 95k 231.38
2023-09-30 $16M 110k 146.04
2023-06-30 $19M 80k 231.00
2023-03-31 $35M 143k 242.26
2022-12-31 $48M 164k 290.25
2022-06-30 $3.8M 53k 71.57
2022-03-31 $4.8M 49k 98.12
2021-12-31 $8.9M 106k 84.74
2021-09-30 $12M 155k 79.79
2021-03-31 $10M 89k 116.97
2020-12-31 $9.0M 81k 111.18
2020-09-30 $16M 138k 118.73
2020-06-30 $12M 105k 113.25
2019-12-31 $15M 165k 91.11
2019-09-30 $9.0M 104k 86.22
2019-06-30 $11M 105k 104.81
2019-03-31 $15M 122k 125.12
2018-12-31 $9.9M 88k 112.68
2018-09-30 $15M 71k 214.13
2018-06-30 $11M 39k 279.68
2018-03-31 $316k 2.7k 116.78
2017-12-31 $458k 5.0k 91.73
2017-03-31 $321k 21k 15.41
2016-09-30 $153k 12k 12.70